OSL
ONCOSIL FPO [OSL]
Healthcare · ASX Small Cap
$0.6550 +0.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical69
Catalyst56
Sentiment50
Fundamental54
Momentum39
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- MACD momentum strengthening
- Stochastic oversold
- Bollinger squeeze (breakout building)
- Near support level (potential bounce)
- Volatility contracting (breakout setup)
- Critical cash runway (0.9 quarters)
- Low P/S ratio (4.1x)
- Strong revenue growth (+222%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (0% of range)
- Micro-cap ($5-20M) - high risk
- Substantial holder(s) ceased (1)
- Capital raise activity (1 events)
- CANSLIM I: Institutional ownership (20%)
- Severe 12-1 momentum decline (-56%)
- Strong revenue momentum (+222%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: NA (est. 2020-07-31)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Appendix 4D and Half Year Accounts
NONE Notice of Extraordinary General Meeting/Proxy Form
NONE Proposed issue of securities - OSL
HIGH Ceasing to be a substantial holder
Recent ASX Announcements
| 2026-02-23 | Appendix 4D and Half Year Accounts PRICE SENSITIVE |
| 2026-02-13 | Ceasing to be a substantial holder |
| 2026-02-11 | Notice of Extraordinary General Meeting/Proxy Form |
| 2026-02-11 | Proposed issue of securities - OSL |
| 2026-02-11 | CEO Remuneration Update PRICE SENSITIVE |
Key Metrics
$15.3M
Market Cap
126K
Avg Volume
0.7x
Vol Ratio
$0.65 — $2.40
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-208.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | laggard | RS: -8 |
| I | Institutional Sponsorship | pass | Inst: 20% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #51 of 119 · Sector avg: 51
View all Healthcare signals →